Division of Neurology, Department of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.
Neurophysiology Laboratory, University of Malaya Medical Centre, Kuala Lumpur 59100, Malaysia.
Medicina (Kaunas). 2023 Apr 11;59(4):747. doi: 10.3390/medicina59040747.
: Studies have suggested that, by applying certain nerve ultrasound scores, demyelinating and axonal polyneuropathies can be differentiated. In the current study, we investigated the utility of ultrasound pattern sub-score A (UPSA) and intra- and internerve cross-sectional area (CSA) variability in the diagnostic evaluation of demyelinating neuropathies. : Nerve ultrasound was performed in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and acute inflammatory demyelinating polyneuropathy (AIDP) and compared to patients with axonal neuropathies. The UPSA, i.e., the sum of ultrasound scores at eight predefined measurement points in the median (forearm, elbow and mid-arm), ulnar (forearm and mid-arm), tibial (popliteal fossa and ankle) and fibular (lateral popliteal fossa) nerves, was applied. Intra- and internerve CSA variability were defined as maximal CSA/minimal CSA for each nerve and each subject, respectively. : A total of 34 CIDP, 15 AIDP and 16 axonal neuropathies (including eight axonal Guillain-Barré syndrome (GBS), four hereditary transthyretin amyloidosis, three diabetic polyneuropathy and one vasculitic neuropathy) were included. A total of 30 age- and sex-matched healthy controls were recruited for comparison. Significantly enlarged nerve CSA was observed in CIDP and AIDP with significantly higher UPSA in CIDP compared to the other groups (9.9 ± 2.9 vs. 5.9 ± 2.0 vs. 4.6 ± 1.9 in AIDP vs. axonal neuropathies, < 0.001). A total of 89.3% of the patients with CIDP had an UPSA score ≥7 compared to the patients with AIDP (33.3%) and axonal neuropathies (25.0%) ( < 0.001). Using this cut-off, the performance of UPSA in differentiating CIDP from other neuropathies including AIDP was excellent (area under the curve of 0.943) with high sensitivity (89.3%), specificity (85.2%) and positive predictive value (73.5%). There were no significant differences in intra- and internerve CSA variability between the three groups. : The UPSA ultrasound score was useful in distinguishing CIDP from other neuropathies compared to nerve CSA alone.
: 研究表明,通过应用某些神经超声评分,可以区分脱髓鞘和轴索性多发性神经病。在本研究中,我们研究了超声模式子评分 A(UPSA)以及神经内和神经间横截面积(CSA)变异性在脱髓鞘性神经病诊断评估中的效用。对慢性炎症性脱髓鞘性多发性神经病(CIDP)和急性炎症性脱髓鞘性多发性神经病(AIDP)患者进行神经超声检查,并与轴索性神经病患者进行比较。UPSA 即 8 个预定测量点(正中神经前臂、肘部和上臂、尺神经前臂和上臂、胫神经腘窝和踝部、腓总神经外侧腘窝)的超声评分总和。神经内和神经间 CSA 变异性分别定义为每个神经和每个受试者的最大 CSA/最小 CSA。: 共纳入 34 例 CIDP、15 例 AIDP 和 16 例轴索性神经病(包括 8 例轴索性吉兰-巴雷综合征(GBS)、4 例遗传性转甲状腺素蛋白淀粉样变性、3 例糖尿病多发性神经病和 1 例血管炎性神经病)。共招募 30 名年龄和性别匹配的健康对照者进行比较。CIDP 和 AIDP 患者的神经 CSA 明显增大,CIDP 患者的 UPSA 明显高于其他组(9.9 ± 2.9 比 5.9 ± 2.0 比 4.6 ± 1.9,AIDP 比轴索性神经病,<0.001)。与 AIDP(33.3%)和轴索性神经病(25.0%)相比,89.3%的 CIDP 患者的 UPSA 评分≥7(<0.001)。使用该截止值,UPSA 在区分 CIDP 与包括 AIDP 在内的其他神经病方面的表现非常出色(曲线下面积为 0.943),具有高敏感性(89.3%)、特异性(85.2%)和阳性预测值(73.5%)。三组间神经内和神经间 CSA 变异性无显著差异。: UPSA 超声评分与神经 CSA 相比,可用于区分 CIDP 与其他神经病。